0
Obstructive Lung Diseases |

Does Low Vitamin D Amplify the Association of COPD With Total and Cardiovascular Disease Mortality?

Hwa Lee*, MD; Yanting Luo, MS; Katherine Lee; Nathan Wong, PhD
Author and Funding Information

Heart Disease Prevention Program, Division of Cardiology, School of Medicine, University of California, Irvine, Irvine, CA


Chest. 2012;142(4_MeetingAbstracts):655A. doi:10.1378/chest.1386490
Text Size: A A A
Published online

Abstract

SESSION TYPE: COPD Posters II

PRESENTED ON: Wednesday, October 24, 2012 at 01:30 PM - 02:30 PM

PURPOSE: Chronic obstructive pulmonary disease (COPD) has been shown to be associated with lower levels of serum 25-hydroxy vitamin D and the latter has been associated with total and cardiovascular disease (CVD) mortality. We examined whether lower vitamin D levels may further amplify the association of COPD and its severity with total and CVD mortality.

METHODS: We studied 7,474 U.S. adults ≥40 years from the National Health and Nutrition Examination Survey 1988-1994 with a mean age of 59.8 years and follow-up through 2006 (8.2±2.5 years) for total and CVD mortality. With vitamin D levels categorized into tertiles and COPD severity classified on the basis of forced expiratory volume in one second (FEV1): mild (FEV1 80%), moderate/severe (FEV1<80%), 24.3% of the subjects had COPD (FEV1/FVC ratio<70%). With Cox regression, we examined the hazard ratios (HR)( 95% confidence intervals) for total and CVD mortality according to COPD/vitamin D category, using those with no COPD in the highest tertile of vitamin D as reference group.

RESULTS: The HRs (unadjusted) increased successively by increasing COPD and decreasing vitamin D group to 4.5(3.3-6.1) for total and 3.4(2.2-5.3) for CVD mortality among those with moderate/severe COPD who were in the 1sttertile of vitamin D. After adjustment for age, gender, ethnicity, body mass index, total and HDL-cholesterol, triglycerides, systolic blood pressure, diabetes, and smoking, these associations were attenuated but remained increased (HR=2.1[1.5-2.9] for total mortality and HR=1.5[1.0-2.4] for CVD mortality). Lower vitamin D tertiles were associated with increasing HRs for total and CVD mortality within each COPD group.

CONCLUSIONS: Our study suggests lower levels of vitamin D may be associated with further increases in total and CVD mortality associated with COPD; however, age and cardiovascular risk factors appear to explain much of this association.

CLINICAL IMPLICATIONS: Measurement of serum vitamin D levels as only modest clinical utility for prognostic risk assessment in persons with COPD. Clinical trials would provide more definitive information about whether vitamin D may be protective in such persons.

DISCLOSURE: The following authors have nothing to disclose: Hwa Lee, Yanting Luo, Katherine Lee, Nathan Wong

No Product/Research Disclosure Information

Heart Disease Prevention Program, Division of Cardiology, School of Medicine, University of California, Irvine, Irvine, CA

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Find Similar Articles
CHEST Journal Articles
PubMed Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543